Author:
Qiang Min,Dong Xue,Zha Zhao,Zuo Xiao-Kun,Song Xing-Lei,Zhao Lixia,Yuan Chao,Huang Chen,Tao Pingdong,Hu Qin,Li Wei-Guang,Hu Wanhui,Li Jie,Nie Yan,Buratto Damiano,Zonta Francesco,Ma Peixiang,Yu Zheng,Liu Lili,Zhang Yi,Yang Bei,Xie Jia,Xu Tian-Le,Qu Zhihu,Yang Guang,Lerner Richard A.
Abstract
Acid-sensing ion channels (ASICs) have emerged as important, albeit challenging therapeutic targets for pain, stroke, etc. One approach to developing therapeutic agents could involve the generation of functional antibodies against these channels. To select such antibodies, we used channels assembled in nanodiscs, such that the target ASIC1a has a configuration as close as possible to its natural state in the plasma membrane. This methodology allowed selection of functional antibodies that inhibit acid-induced opening of the channel in a dose-dependent way. In addition to regulation of pH, these antibodies block the transport of cations, including calcium, thereby preventing acid-induced cell death in vitro and in vivo. As proof of concept for the use of these antibodies to modulate ion channels in vivo, we showed that they potently protect brain cells from death after an ischemic stroke. Thus, the methodology described here should be general, thereby allowing selection of antibodies to other important ASICs, such as those involved in pain, neurodegeneration, and other conditions.
Publisher
Proceedings of the National Academy of Sciences
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献